Elucidating the role of Staphylococcus epidermidis serine–aspartate repeat protein G in platelet activation

Summary.  Background: Staphylococcus epidermidis is a commensal of the human skin that has been implicated in infective endocarditis and infections involving implanted medical devices. S. epidermidis induces platelet aggregation by an unknown mechanism. The fibrinogen‐binding protein serine–aspartate repeat protein G (SdrG) is present in 67–91% of clinical strains. Objectives: To determine whether SdrG plays a role in platelet activation, and if so to investigate the role of fibrinogen in this mechanism. Methods: SdrG was expressed in a surrogate host, Lactococcus lactis, in order to investigate its role in the absence of other staphylococcal components. Platelet adhesion and platelet aggregation assays were employed. Results:  L. lactis expressing SdrG stimulated platelet aggregation (lag time: 2.9 ± 0.5 min), whereas the L. lactis control did not. L. lactis SdrG‐induced aggregation was inhibited by αIIbβ3 antagonists and aspirin. Aggregation was dependent on both fibrinogen and IgG, and the platelet IgG receptor FcγRIIa. Preincubation of the bacteria with Bβ‐chain fibrinopeptide inhibited aggregation (delaying the lag time six‐fold), suggesting that fibrinogen acts as a bridging molecule. Platelets adhered to L. lactis SdrG in the absence of fibrinogen. Adhesion was inhibited by αIIbβ3 antagonists, suggesting that this direct interaction involves αIIbβ3. Investigation using purified fragments of SdrG revealed a direct interaction with the B‐domains. Adhesion to the A‐domain involved both a fibrinogen and an IgG bridge. Conclusion: SdrG alone is sufficient to support platelet adhesion and aggregation through both direct and indirect mechanisms.

[1]  Cunji Gao,et al.  Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. , 2008, Blood.

[2]  B. Sellman,et al.  Expression of Staphylococcus epidermidis SdrG Increases following Exposure to an In Vivo Environment , 2008, Infection and Immunity.

[3]  T. Foster,et al.  Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the αC-domain of human fibrinogen , 2008, Microbiology.

[4]  T. Foster,et al.  Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor B , 2007, Infection and Immunity.

[5]  Richard J. Edwards,et al.  Bioinformatic discovery of novel bioactive peptides. , 2007, Nature chemical biology.

[6]  杜昕,et al.  Infective endocarditis , 2007 .

[7]  L. Visai,et al.  Fibronectin‐binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcγRIIa receptor , 2006, Molecular microbiology.

[8]  T. Foster,et al.  Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A , 2005, Molecular microbiology.

[9]  C. R. Arciola,et al.  Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections. , 2004, Biomaterials.

[10]  D. O'Connell.  Microbial adhesion: Dock, lock and latch , 2003, Nature Reviews Microbiology.

[11]  Magnus Hook,et al.  A “dock, lock, and latch” Structural Model for a Staphylococcal Adhesin Binding to Fibrinogen , 2003, Cell.

[12]  M. Byrne,et al.  Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. , 2003, Gastroenterology.

[13]  Z. Ruggeri,et al.  Induction of platelet thrombi by bacteria and antibodies. , 2002, Blood.

[14]  D. Fitzgerald,et al.  Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A , 2002, Molecular microbiology.

[15]  J. Flock,et al.  Lack of fbe, the gene for a fibrinogen-binding protein from Staphylococcus epidermidis, reduces its adherence to fibrinogen coated surfaces. , 2001, Microbial pathogenesis.

[16]  T. Foster,et al.  The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. , 2001, Microbiology.

[17]  G. Delage,et al.  A fatal case of transfusion‐transmitted Staphylococcus epidermidis sepsis , 2001, Transfusion.

[18]  M. Höök,et al.  SdrG, a Fibrinogen-binding Bacterial Adhesin of the Microbial Surface Components Recognizing Adhesive Matrix Molecules Subfamily from Staphylococcus epidermidis, Targets the Thrombin Cleavage Site in the Bβ Chain* , 2001, The Journal of Biological Chemistry.

[19]  J. Flock,et al.  Functional study of antibodies against a fibrogenin-binding protein in Staphylococcus epidermidis adherence to polyethylene catheters. , 2001, The Journal of infectious diseases.

[20]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[21]  G. Lina,et al.  The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. , 2000, Microbiology.

[22]  M. Höök,et al.  The Fibronectin-binding MSCRAMM FnbpA ofStaphylococcus aureus Is a Bifunctional Protein That Also Binds to Fibrinogen* , 2000, The Journal of Biological Chemistry.

[23]  B. Guss,et al.  Functional Studies of a Fibrinogen Binding Protein from Staphylococcus epidermidis , 1999, Infection and Immunity.

[24]  T. Foster,et al.  Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. , 1998, Microbiology.

[25]  P. François,et al.  Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus , 1998, Molecular microbiology.

[26]  T. Foster,et al.  The Fibrinogen-binding MSCRAMM (Clumping Factor) ofStaphylococcus aureus Has a Ca2+-dependent Inhibitory Site* , 1998, The Journal of Biological Chemistry.

[27]  P. François,et al.  The dipeptide repeat region of the fibrinogen‐binding protein (clumping factor) is required for functional expression of the fibrinogen‐binding domain on the Staphylococcus aureus cell surface , 1997, Molecular microbiology.

[28]  L. McIntire,et al.  Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. , 1997, European journal of biochemistry.

[29]  D. Cox,et al.  Pentamidine Is a Specific, Non-Peptide, GPIIb/llla Antagonist , 1996, Thrombosis and Haemostasis.

[30]  H. Lazarus,et al.  A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets , 1993, Transfusion.

[31]  M. Terpenning.  Infective endocarditis. , 1992, Clinics in geriatric medicine.

[32]  Y. Ichiman,et al.  Platelet Aggregation Induced by Strains of Various Species of Coagulase‐Negative Staphylococci , 1991, Microbiology and immunology.

[33]  P. Sullam,et al.  Role of immunoglobulin G in platelet aggregation by viridans group streptococci , 1988, Infection and immunity.

[34]  D. Connolly,et al.  Determination of the number of endothelial cells in culture using an acid phosphatase assay. , 1986, Analytical biochemistry.

[35]  I. Peake.  International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.

[36]  E. Quinn,et al.  STAPHYLOCOCCUS ALBUS (EPIDERMIDIS) ENDOCARDITIS: REPORT OF 16 CASES SEEN BETWEEN 1953 AND 1962. , 1963, Antimicrobial agents and chemotherapy.

[37]  a fatal case , 2022 .

[38]  L. Pei.  A Fibrinogen-Binding Protein from Staphylococcus epidermidis , 2022 .